Emrelis Injection, Powder, Lyophilized, For Solution
Product Images NDC 0074-1044

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emrelis (NDC 0074-1044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Telisotuzumab Vedotin-tllv Is A C-met Directed Antibody-drug Conjugate (adc) Comprised Of A Humanized Immunoglobulin G1 Kappa (igg1κ) Monoclonal Antibody Conjugated To The Small Molecule Microtubule-disrupting Agent, Monomethyl Auristatin E (mmae), Via A Protease-cleavable Valine-citrulline (vc) Linker. The Antibody Is Produced In A Mammalian Cell Line (chinese Hamster Ovary) And The Drug-linker Is Produced By Chemical Synthesis. Each Monoclonal Antibody Molecule Carries An Average Of 3 Mmae Molecules. Telisotuzumab Vedotin-tllv Has An Approximate Molecular Weight Of 152 Kda. (Emrelis Teliso V 01)

Telisotuzumab Vedotin-tllv Is A C-met Directed Antibody-drug Conjugate (adc) Comprised Of A Humanized Immunoglobulin G1 Kappa (igg1κ) Monoclonal Antibody Conjugated To The Small Molecule Microtubule-disrupting Agent, Monomethyl Auristatin E (mmae), Via A Protease-cleavable Valine-citrulline (vc) Linker. The Antibody Is Produced In A Mammalian Cell Line (chinese Hamster Ovary) And The Drug-linker Is Produced By Chemical Synthesis. Each Monoclonal Antibody Molecule Carries An Average Of 3 Mmae Molecules. Telisotuzumab Vedotin-tllv Has An Approximate Molecular Weight Of 152 Kda. (Emrelis Teliso V 01)
Chemical structure of telisotuzumab vedotin showing the antibody linked to maleimidocaproyl, PABA, and MMAE components with a defined average molecular composition.*
FDA Label Image

Principal Display Panelndc 0074-1044-01emrelis™(telisotuzumab Vedotin-tllv)for Injection20 mg Per Vialhazardous Drugfor Intravenous Infusion After Reconstitutionand Dilutionsingle-dose Vialdiscard Unused Portiondispense The Enclosed Medication Guide To Each Patientrx Onlyabbvie (Emrelis Teliso V 02)

Principal Display Panelndc 0074-1044-01emrelis™(telisotuzumab Vedotin-tllv)for Injection20 mg Per Vialhazardous Drugfor Intravenous Infusion After Reconstitutionand Dilutionsingle-dose Vialdiscard Unused Portiondispense The Enclosed Medication Guide To Each Patientrx Onlyabbvie (Emrelis Teliso V 02)
Label for Emrelis (telisotuzumab vedotin-tillv) injection, powder, lyophilized, for solution. Displays concentration of 20 mg per vial. Indicates it is for intravenous infusion after reconstitution and dilution. Notes single-dose vial and discard unused portion. Manufactured by AbbVie Inc. with NDC 0074-1044-01. Contains usage and storage instructions including refrigeration at 2°C to 8°C and preparation guidelines.*
FDA Label Image

Principal Display Panelndc 0074-1055-01emrelis™(telisotuzumab Vedotin-tllv)for Injection100 mg Per Vialhazardous Drugfor Intravenous Infusion After Reconstitutionand Dilutionsingle-dose Vialdiscard Unused Portiondispense The Enclosed Medication Guide To Each Patientrx Onlyabbvie (Emrelis Teliso V 03)

Principal Display Panelndc 0074-1055-01emrelis™(telisotuzumab Vedotin-tllv)for Injection100 mg Per Vialhazardous Drugfor Intravenous Infusion After Reconstitutionand Dilutionsingle-dose Vialdiscard Unused Portiondispense The Enclosed Medication Guide To Each Patientrx Onlyabbvie (Emrelis Teliso V 03)
Emrelis (telisotuzumab vedotin-tllv) injection 100 mg per vial, lyophilized powder for intravenous infusion, single-dose vial labeled as a hazardous drug. Manufactured by AbbVie Inc., North Chicago, IL. The label includes storage instructions, reconstitution and dilution guidelines, and dispensing information, with Rx only and U.S. License No. 1889 shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.